987 results on '"Lucci, Anthony"'
Search Results
2. Contemporary Analysis of Reexcision and Conversion to Mastectomy Rates and Associated Healthcare Costs for Women Undergoing Breast-Conserving Surgery
3. ASO Visual Abstract: Self-Reported Management of Inflammatory Breast Cancer Among the American Society of Breast Surgeons Membership—Consensus and Opportunities
4. Monitoring response to neoadjuvant chemotherapy in triple negative breast cancer using circulating tumor DNA
5. ASO Visual Abstract: Contemporary Analysis of Re-Excision and Conversion to Mastectomy Rates and Associated Health Care Costs for Women Undergoing Breast-Conserving Surgery
6. Great Debate: The Surgeon’s Role in Locoregional Management of Stage IV Breast Cancer
7. Extremely Low Incidence of Local-Regional Recurrences Observed Among T1-2 N1 (1 or 2 Positive SLNs) Breast Cancer Patients Receiving Upfront Mastectomy Without Completion Axillary Node Dissection
8. Correction: Contemporary Analysis of Reexcision and Conversion to Mastectomy Rates and Associated Healthcare Costs for Women Undergoing Breast-Conserving Surgery
9. Low Rates of Local-Regional Recurrence Among Inflammatory Breast Cancer Patients After Contemporary Trimodal Therapy
10. Is there a role for liquid biopsy in the surveillance of parathyroid carcinoma?
11. ASO Visual Abstract: Extremely Low Incidence of Local–Regional Recurrences Observed among T1–2N1 (one or two Positive SLNs) Breast Cancer Patients Receiving Upfront Mastectomy without Completion Axillary Node Dissection
12. Neoadjuvant relatlimab and nivolumab in resectable melanoma
13. ASO Author Reflections: Low Rates of Local-Regional Recurrence in Inflammatory Breast Cancer Patients After Contemporary Trimodal Therapy
14. ASO Visual Abstract: Low Rates of Local-Regional Recurrence in Inflammatory Breast Cancer Patients After Contemporary Trimodal Therapy
15. B cells and tertiary lymphoid structures promote immunotherapy response
16. Lymphedema in Inflammatory Breast Cancer Patients Following Trimodal Treatment
17. Long-term Oncologic Outcomes in Patients with Inflammatory Breast Cancer with Supraclavicular Nodal Involvement
18. Therapeutics of Oxidative Stress and Stemness in Breast Cancer
19. Androgen receptor blockade promotes response to BRAF/MEK-targeted therapy
20. Eliminating breast surgery for invasive breast cancer in exceptional responders to neoadjuvant systemic therapy: a multicentre, single-arm, phase 2 trial
21. Immediate Breast Reconstruction in Inflammatory Breast Cancer: Are We There Yet?
22. Monitoring Response to Neoadjuvant Chemotherapy in Triple Negative Breast Cancer Using Circulating Tumor DNA
23. Circulating Tumor Cells in Breast Cancer
24. Clinical Course of Breast Cancer Patients with Local-Regional Progression During Neoadjuvant Systemic Therapy
25. Inflammatory Breast Cancer at the Extremes of Age
26. Current Surgical Management of Inflammatory Breast Cancer
27. The Role of Mastectomy in De Novo Stage IV Inflammatory Breast Cancer
28. Measurement of Portal Vein Blood Circulating Tumor Cells is Safe and May Correlate With Outcomes in Resected Pancreatic Ductal Adenocarcinoma
29. ASO Visual Abstract: Long-Term Oncologic Outcomes in Patients with Inflammatory Breast Cancer with Supraclavicular Nodal Involvement
30. Author Correction: Neoadjuvant relatlimab and nivolumab in resectable melanoma
31. Nodal Recurrence is a Primary Driver of Early Relapse for Patients with Sentinel Lymph Node-Positive Melanoma in the Modern Therapeutic Era
32. ASO Visual Abstract: Lymphedema in Inflammatory Breast Cancer Patients Following Trimodal Treatment
33. Author Correction: Androgen receptor blockade promotes response to BRAF/MEK-targeted therapy
34. Is there a role for liquid biopsy in the surveillance of parathyroid carcinoma?
35. ASO Visual Abstract: Clinical Course of Breast Cancer Patients with Local Regional Progression During Neoadjuvant Systemic Therapy
36. Correlation of circulating or disseminated tumor cells with the Oncotype DX Recurrence Score
37. Factors Associated with Pathological Node Negativity in Inflammatory Breast Cancer: Are There Patients Who May be Candidates for a De-Escalation of Axillary Surgery?
38. Excellent Locoregional Control in Inflammatory Breast Cancer With a Personalized Radiation Therapy Approach
39. Changes in Triple-Negative Breast Cancer Molecular Subtypes in Patients Without Pathologic Complete Response After Neoadjuvant Systemic Chemotherapy
40. Liquid Biopsy as Effective Predictor of Stage III Melanoma Relapse
41. Therapeutics of Oxidative Stress and Stemness in Breast Cancer
42. ASO Visual Abstract: Contralateral Axillary Metastasis in Patients with Inflammatory Breast Cancer
43. 1534 Clinical activity of SD-101 with immune checkpoint inhibition (ICI) in metastatic uveal melanoma liver metastasis (MUM-LM) from the PERIO-01 Phase 1 trial
44. Inflammatory Breast Cancer: What to Know About This Unique, Aggressive Breast Cancer
45. Circulating Tumor Cells in Stage IV Melanoma Patients
46. Prospective Feasibility Trial of Sentinel Lymph Node Biopsy in the Setting of Inflammatory Breast Cancer
47. ASO Author Reflections: The Multidisciplinary Approach to de Novo Metastatic Inflammatory Breast Cancer: A Combined Systemic and Locoregional Strategy
48. Role of Liquid Biopsy in Clinical Decision-Making for Breast Cancer
49. Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma
50. ASO Visual Abstract: Inflammatory Breast Cancer at the Extremes of Age
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.